0000313143-14-000107.txt : 20141024 0000313143-14-000107.hdr.sgml : 20141024 20141024193257 ACCESSION NUMBER: 0000313143-14-000107 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141022 FILED AS OF DATE: 20141024 DATE AS OF CHANGE: 20141024 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HAEMONETICS CORP CENTRAL INDEX KEY: 0000313143 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042882273 STATE OF INCORPORATION: MA FISCAL YEAR END: 0330 BUSINESS ADDRESS: STREET 1: 400 WOOD RD CITY: BRAINTREE STATE: MA ZIP: 02184 BUSINESS PHONE: 7818487100 MAIL ADDRESS: STREET 1: 400 WOOD ROAD CITY: BRAINTREE STATE: MA ZIP: 02184 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Davies Kent J CENTRAL INDEX KEY: 0001351454 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14041 FILM NUMBER: 141173333 MAIL ADDRESS: STREET 1: 400 WOOD ROAD CITY: BRAINTREE STATE: MA ZIP: 02184 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2014-10-22 0 0000313143 HAEMONETICS CORP HAE 0001351454 Davies Kent J 400 WOOD ROAD BRAINTREE MA 02184 0 1 0 0 President, Global Markets Common Stock 2014-10-22 4 A 0 3417.0 0.0 A 6819 D Non-Qualified Stock Option (right to buy) 34.745 2014-10-22 4 A 0 15166.0 0.0 A 2015-10-22 2024-10-22 Common Stock 15166 15166 D Performance Shares 0.0 2014-10-22 4 A 0 6834.0 0.0 A 2017-09-30 2017-12-31 Common Stock 6834 26411 D Restricted Stock Unit Grant which vest 25% per year over 4 years following the grant date. Grant was made under 2005 Long Term Incentive Compensation Plan. Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant. Performance Share Units represent a right to receive one share of Haemonetics Corporation common stock for each Performance Stock Unit based on the performance of Haemonetics stock price relative to the Standard & Poors Health Care Equipment Index. The number of Performance Stock Units (and therefore the number of shares payable) will depend on the Company's stock price performance between October 1, 2014 and September 30, 2017. The Performance Stock Units disclosed in column 5 represent a target amount. The number of shares ultimately issued could range from none to twice the target amount in column 5. The Performance Stock Units were granted under the 2005 Haemonetics Corporation Long-Term Incentive Compensation Plan and are exempt under Rule 16b-3(d). By: Alexander Steffan For: Kent Davies 2014-10-24